Patents Assigned to Utah Ventures II, L.P.
  • Methods for identifying and isolating tissue-specific lumen-exposed molecules
    Patent number: 6903196
    Abstract: This invention provides novel methods of and kits for labeling and isolating lumen-exposed molecules, particularly polypeptides which are expressed in a tissue-specific or organ-specific manner. The methods and kits can be used to isolate molecules exposed on the luminal side of cells lining vascular, ductal, sinus, respiratory, fascial, and other perfusible tissue spaces.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: June 7, 2005
    Assignee: Utah Ventures II, L.P.
    Inventors: Paul Roben, Anthony C. Stevens
  • Lumen-exposed molecules and methods for targeted delivery
    Publication number: 20040146516
    Abstract: The present invention provides novel methods and kits for labeling and isolating tissue-specific or organ-specific lumen-exposed molecules. In addition, the present invention provides tissue-specific or organ-specific lumen-exposed polypeptides, which were isolated by the methods herein. Furthermore the present invention provides therapeutic complexes comprising ligands that bind the tissue-specific or organ-specific lumen-exposed polypeptides attached to therapeutic moieties for targeted treatment and prevention.
    Type: Application
    Filed: March 5, 2004
    Publication date: July 29, 2004
    Applicant: Utah Ventures II L.P.
    Inventors: Paul Roben, Anthony C. Stevens